Vanguard Personalized Indexing Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$6.09 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$45.8 - $85.4 $217,779 - $406,077	-4,755 Reduced 51.15%	4,541 $271,000
Q1 2022 May 16, 2022	SELL	$62.2 - $84.4 $235,738 - $319,876	-3,790 Reduced 28.96%	9,296 $675,000
Q4 2021 Feb 23, 2022	BUY	$73.71 - $87.86 $512,063 - $610,363	6,947 Added 113.16%	13,086 $1.1 Million
Q3 2021 Nov 09, 2021	BUY	$77.92 - $102.4 $478,350 - $628,633	6,139 New	6,139 $554,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.5M

Call Options Held

520K

Put Options Held

406K

Vanguard Group Inc Valley Forge, PA

9.95M
Shares

$446 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$251 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.12M
Shares

$230 Million
0.91% of portfolio
Wellington Management Group LLP Boston, MA

4.17M
Shares

$187 Million
0.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.07M
Shares

$138 Million
0.02% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account